Temperature excursion: difference between revisions
Diff·revision 24 → 25·16:23, 23 Jan 2026
Difference between revision 24 and revision 25 of Temperature excursion. 6 lines changed; the page grew by 1,040 bytes.
| Revision 24 — 17:23, 6 Jan 2026 SPPS_Sorrel (talk) the article confused primary and secondary drying; corrected 22,977 bytes +858 | Revision 25 — 16:23, 23 Jan 2026 Areapercent_Ayo (talk) state that a phase-change pack and a gel pack behave differently 24,017 bytes +1,040 | ||
|---|---|---|---|
| 128 | Two structural features of this sequence are worth noting. It is asymmetric in favour of rejection, because the burden is to show that quality is unaffected rather than to show that it is affected. And it depends at step 4 on data that exist only for products with a stability programme, which is why the sequence cannot be applied outside regulated distribution however carefully the temperature was recorded.{{r|ich_q1a}} | 128 | Two structural features of this sequence are worth noting. It is asymmetric in favour of rejection, because the burden is to show that quality is unaffected rather than to show that it is affected. And it depends at step 4 on data that exist only for products with a stability programme, which is why the sequence cannot be applied outside regulated distribution however carefully the temperature was recorded.{{r|ich_q1a}} |
| 129 | 129 | ||
| + | 130 | Cumulative accounting is the step most often omitted. A consignment may pass three separate excursion assessments individually and fail the same criteria when the exposures are summed, and guidance is explicit that the accounting is cumulative across the product's life rather than per event.{{r|whotrs961}} | |
| + | 131 | ||
| 130 | === What a stability-indicating assay is asked to demonstrate === | 132 | === What a stability-indicating assay is asked to demonstrate === |
| 131 | A ''stability-indicating'' method is one shown to resolve the intact substance from its degradation products, so that a change in the assay result can be attributed to degradation rather than to variability. Demonstrating that property is a validation exercise, and the demonstration is conventionally made by forced degradation: the substance is deliberately stressed by heat, humidity, acid, base, oxidant and light, and the method is shown to separate and quantify what results, with mass balance accounted for.{{r|ich_q1a,manning2010}} | 133 | A ''stability-indicating'' method is one shown to resolve the intact substance from its degradation products, so that a change in the assay result can be attributed to degradation rather than to variability. Demonstrating that property is a validation exercise, and the demonstration is conventionally made by forced degradation: the substance is deliberately stressed by heat, humidity, acid, base, oxidant and light, and the method is shown to separate and quantify what results, with mass balance accounted for.{{r|ich_q1a,manning2010}} |
| ⋮ | ⋮ | ||
| 140 | Two limitations are structural. Without a pre-excursion result for the same lot, a purity figure establishes only the current state, not a change; the retained sample is therefore the critical asset, and its absence is what most often makes a post-hoc assessment impossible. And a method's limit of detection sets a floor below which no statement can be made: an assay resolving 0.1% of a degradation product cannot demonstrate the absence of 0.05%, and a report of no detected change means no change above that floor rather than no change.{{r|ich_q1a}} | 142 | Two limitations are structural. Without a pre-excursion result for the same lot, a purity figure establishes only the current state, not a change; the retained sample is therefore the critical asset, and its absence is what most often makes a post-hoc assessment impossible. And a method's limit of detection sets a floor below which no statement can be made: an assay resolving 0.1% of a degradation product cannot demonstrate the absence of 0.05%, and a report of no detected change means no change above that floor rather than no change.{{r|ich_q1a}} |
| 141 | 143 | ||
| + | 144 | {{seealso|Analytical method validation|Limit of detection}} | |
| + | 145 | ||
| 142 | == Evidence quality outside regulated distribution == | 146 | == Evidence quality outside regulated distribution == |
| 143 | Where material is distributed without a stability programme, records or retained samples, the assessment machinery described above has no inputs. What remains is inference from general chemistry and observation by recipients, and the two are of very different value. | 147 | Where material is distributed without a stability programme, records or retained samples, the assessment machinery described above has no inputs. What remains is inference from general chemistry and observation by recipients, and the two are of very different value. |
| 144 | 148 | ||
| 145 | Inference from chemistry supports statements of the form that a dry lyophilised peptide sealed in a vial is expected to tolerate transient warming far better than the same peptide in aqueous solution. That is a well-supported general proposition. It does not support a statement about a particular parcel, because the parameters that determine the outcome — the glass transition temperature of that formulation, the moisture content, the integrity of the closure, the actual exposure — are all unmeasured.{{r|ich_q1a,ppexcursion}} | 149 | Inference from chemistry supports statements of the form that a dry lyophilised peptide sealed in a vial is expected to tolerate transient warming far better than the same peptide in aqueous solution. That is a well-supported general proposition. It does not support a statement about a particular parcel, because the parameters that determine the outcome — the glass transition temperature of that formulation, the moisture content, the integrity of the closure, the actual exposure — are all unmeasured.{{r|ich_q1a,ppexcursion}} |
| + | 150 | ||
| + | 151 | Recipient observation is weaker than it appears. Community reports that material used after warm transit produced no noticeable difference in effect suffer from a specific set of defects: no pre-exposure analytical baseline, so any deficit cannot be attributed to transit; no measurement of the exposure, so the reported condition is a guess; no blinding, and a subjective endpoint; and survivorship, since material that was visibly ruined is discarded rather than reported. The absence of a noticed difference is also a low-sensitivity endpoint — a 15% loss of active peptide is unlikely to be perceptible and would be a serious analytical finding.{{r|ppexcursion}} | |
| 146 | 152 | ||
| 147 | == References == | 153 | == References == |